USPTO serial 79446401
ARC
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- MESSICK, TABITHA LEE
- Law office
- TMEG LAW OFFICE 104
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with ARC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consultancy relating to the commercialization of medical products and technologies; business management of all types (commercial, operation, development and marketing) of development centers and business incubators in the fields of medical products and technologies; commercialization of medical products and technologies, namely: sales prospecting, sales promotion, sales strategy, marketing, marketing strategy, retail and wholesale distribution and commercial administration of licensing, all with respect to medical products and technologies, for others; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposes, veterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticals, anti-cancer preparations, biological preparations, or vaccine preparations | ACTIVE | — |
| 042 | Consultancy relating to the development of medical products and technologies; design and development of medical products and technologies; all the foregoing not in relation to the actual performance of research and development of (1) gene and DNA analysis and sequencing for medical diagnostic purposes, veterinary diagnostics purposes and for use in cancer diagnosis and treatment or (2) pharmaceuticals, anticancer preparations, biological preparations, or vaccine preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 24, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 24, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 24, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 19, 2026 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |